Inamed Outlines Facial Aesthetic Pipeline; Focuses On Lap-Band Sales Growth
This article was originally published in The Gray Sheet
Executive Summary
Inamed anticipates receiving FDA approval for its Cosmoderm and Cosmoplast tissue engineered human collagen products for wrinkle reduction by year-end
You may also be interested in...
Silicone Breast Implant Return To U.S. Market Heralded By Modular PMA
Inamed likely will be first to the U.S. market with a silicone gel-filled breast implant in the wake of FDA's 1992 call for PMAs for the pre-amendments devices
Inamed Plans Major Training Push To Speed Adoption Of LAP-BAND
Inamed/BioEnterics hopes to have 100 centers trained and qualified to use the LAP-BAND adjustable gastric banding system by the end of 2001.
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.